Talphera (TLPH) Research & Development (2010 - 2026)

Talphera (TLPH) recorded quarterly Research & Development of $1.6 million in Q1 2026, down 8.49% quarter-over-quarter from $1.8 million in Q3 2025, and up 41.15% on a YoY basis from $1.2 million in Q1 2025.

Talphera (TLPH) Research & Development (2010 - 2026) Analysis & Trends

Talphera's Research & Development history runs 17 years deep, the most recent figure standing at $1.6 million for Q1 2026.

  • In Q1 2026, Research & Development rose 41.15% year-over-year to $1.6 million; the TTM figure through Mar 2026 stood at $6.1 million (down 5.14% YoY), while the FY2024 annual figure was $6.7 million, up 21.13% from the prior year.
  • Research & Development was $1.6 million for Q1 2026 at Talphera, down from $1.8 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $2.1 million in Q3 2024 to a low of $612000.0 in Q4 2022.
  • Historically, Research & Development has averaged $1.4 million across 5 years, with a median of $1.4 million in 2024.
  • The sharpest annual moves came in 2022 and 2023: Research & Development tumbled 43.57% in 2022, then surged 189.05% in 2023.
  • A 5-year view of Research & Development shows it stood at $612000.0 in 2022, then soared by 189.05% to $1.8 million in 2023, then dropped by 25.21% to $1.3 million in 2024, then soared by 36.28% to $1.8 million in 2025, then declined by 8.49% to $1.6 million in 2026.
  • The last three Research & Development figures came in at $1.6 million (Q1 2026), $1.8 million (Q3 2025), and $1.5 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 222.00 Mn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 180.00 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 138.20 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 934,363.43
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 296.20 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 97.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 103.35 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 39.38 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 46.94 Mn
10 Talphera 59.35 Mn 59.35 Mn - 1.65 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.65 Mn
Sep 30, 2025 1.80 Mn
Jun 30, 2025 1.50 Mn
Mar 31, 2025 1.17 Mn
Dec 31, 2024 1.32 Mn
Sep 30, 2024 2.05 Mn
Jun 30, 2024 1.91 Mn
Mar 31, 2024 1.43 Mn
Dec 31, 2023 1.77 Mn
Sep 30, 2023 1.18 Mn
Jun 30, 2023 1.55 Mn
Mar 31, 2023 1.05 Mn
Dec 31, 2022 612,000.00
Sep 30, 2022 799,000.00
Jun 30, 2022 1.09 Mn
Mar 31, 2022 836,000.00
Dec 31, 2021 986,000.00
Sep 30, 2021 1.42 Mn
Jun 30, 2021 724,000.00
Mar 31, 2021 969,000.00